PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, giving promising advancements throughout various healthcare and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, additional reliable choice for therapeutic use, si